Leila Pirhaji, CEO of ReviveMed, on AI for Metabolomics
On this episode, I speak with Leila Pirhaji, founder and CEO of ReviveMed ( www.revive-med.com ). ReviveMed uses artificial intelligence to unlock the therapeutic potential of metabolomics. Before lea...
11 Kesä 201828min
Mostapha Benhenda of Startcrowd on AI Drug Discovery Hype
On this episode, I speak with Mostapha Benhenda of Startcrowd ( http://www.startcrowd.club ). In January, Mostapha wrote a controversial article critiquing several research labs ( https://bit.ly/2qINv...
29 Touko 201820min
Mauro Cozzi, Researchably, AI for Better Biomedical Search
On this episode, I speak with Mauro Cozzi, co-founder of Researchably ( www.researchably.com ). Researchably is a biomedical search engine that uses artificial intelligence to save researchers time—Ma...
22 Touko 201829min
Dekel Gelbman, CEO of FDNA, on "Next-Generation Phenotyping"
For the inaugural episode of Artificial Intelligence in Drug Discovery, I spoke with Dekel Gelbman, CEO of FDNA ( https://www.fdna.com/ ). FDNA enables precision medicine by using artificial intellige...
14 Touko 201830min
